Frontiers in Aging Neuroscience

Papers
(The H4-Index of Frontiers in Aging Neuroscience is 47. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease226
Microglia Polarization From M1 to M2 in Neurodegenerative Diseases206
Machine Learning for the Diagnosis of Parkinson's Disease: A Review of Literature141
Brain Microvascular Pericytes in Vascular Cognitive Impairment and Dementia133
Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD Study127
Cellular Senescence in Brain Aging125
Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia121
The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis107
Cholesterol and Alzheimer’s Disease; From Risk Genes to Pathological Effects106
The Impact of Disease Comorbidities in Alzheimer's Disease102
Mitochondrial Dysfunction and Alzheimer’s Disease: Role of Microglia95
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–201990
The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases90
Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer’s Disease: A Focus on Aducanumab and Lecanemab86
APOE Alleles and Diet in Brain Aging and Alzheimer’s Disease80
Astrocyte Senescence and Alzheimer’s Disease: A Review79
Interleukin-17A: The Key Cytokine in Neurodegenerative Diseases78
The Impact of COVID-19 Quarantine on Patients With Dementia and Family Caregivers: A Nation-Wide Survey77
Resveratrol Derivatives as Potential Treatments for Alzheimer’s and Parkinson’s Disease76
Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?76
Functional Aging in Male C57BL/6J Mice Across the Life-Span: A Systematic Behavioral Analysis of Motor, Emotional, and Memory Function to Define an Aging Phenotype74
Mechanisms of Pathogenic Tau and Aβ Protein Spreading in Alzheimer’s Disease72
Astroglia and Tau: New Perspectives69
Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease67
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease64
The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain63
Alzheimer’s Disease: An Update and Insights Into Pathophysiology62
Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases60
Neuroimmunomodulatory and Neuroprotective Effects of the Flavonoid Apigenin in in vitro Models of Neuroinflammation Associated With Alzheimer’s Disease60
The Role of Resting-State Network Functional Connectivity in Cognitive Aging60
Mild Behavioral Impairment Is Associated With Atrophy of Entorhinal Cortex and Hippocampus in a Memory Clinic Cohort60
Age-Related Olfactory Dysfunction: Epidemiology, Pathophysiology, and Clinical Management59
The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review59
Molecular Chaperones: A Double-Edged Sword in Neurodegenerative Diseases56
Inflammation From Peripheral Organs to the Brain: How Does Systemic Inflammation Cause Neuroinflammation?56
Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough54
Channelrhodopsin Excitation Contracts Brain Pericytes and Reduces Blood Flow in the Aging Mouse Brain in vivo54
Plant-Derived Antioxidants Protect the Nervous System From Aging by Inhibiting Oxidative Stress53
Gut Microbiome Signatures Are Biomarkers for Cognitive Impairment in Patients With Ischemic Stroke52
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease52
Past, Present, and Future of Non-invasive Brain Stimulation Approaches to Treat Cognitive Impairment in Neurodegenerative Diseases: Time for a Comprehensive Critical Review50
Grip Strength and the Risk of Cognitive Decline and Dementia: A Systematic Review and Meta-Analysis of Longitudinal Cohort Studies50
Mitophagy in Cerebral Ischemia and Ischemia/Reperfusion Injury49
Prevalence of Alzheimer's Disease and Parkinson's Disease in China: An Updated Systematical Analysis49
Heterogeneity in Regional Damage Detected by Neuroimaging and Neuropathological Studies in Older Adults With COVID-19: A Cognitive-Neuroscience Systematic Review to Inform the Long-Term Impact of the 48
Detection of Mild Cognitive Impairment Using Convolutional Neural Network: Temporal-Feature Maps of Functional Near-Infrared Spectroscopy48
Nicotinamide, a Poly [ADP-Ribose] Polymerase 1 (PARP-1) Inhibitor, as an Adjunctive Therapy for the Treatment of Alzheimer’s Disease48
0.04302191734314